According to Cassava Sciences 's latest financial reports the company's current EPS (TTM) is -2,09 โฌ. In 2022 the company made an earnings per share (EPS) of -1,81 โฌ a decrease over its 2021 EPS that were of -0,77 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -2,07 โฌ | 14.31% |
2022 | -1,81 โฌ | 134.57% |
2021 | -0,77 โฌ | 224% |
2020 | -0,24 โฌ | -3.85% |
2019 | -0,25 โฌ | -69.05% |
2018 | -0,80 โฌ | -54.1% |
2017 | -1,74 โฌ | -23.11% |
2016 | -2,27 โฌ | 9.68% |
2015 | -2,07 โฌ | 10.71% |
2014 | -1,87 โฌ | -140.58% |
2013 | 4,60 โฌ | -1055.25% |
2012 | -0,48 โฌ | 20.39% |
2011 | -0,40 โฌ | -77.78% |
2010 | -1,80 โฌ | 285.71% |
2009 | -0,47 โฌ | -118.92% |
2008 | 2,47 โฌ | -19.57% |
2007 | 3,07 โฌ | 228.57% |
2006 | 0,93 โฌ | -120% |
2005 | -4,67 โฌ | -31.37% |
2004 | -6,80 โฌ | 39.73% |
2003 | -4,87 โฌ | 23.73% |
2002 | -3,93 โฌ | 5.36% |
2001 | -3,73 โฌ | -38.46% |
2000 | -6,07 โฌ |